Revisiting FDA approval of aducanumab

G. Caleb Alexander; David S. Knopman; Scott S. Emerson; Bruce Ovbiagele; Richard J. Kryscio; Joel S. Perlmutter; Aaron S. Kesselheim

doi:10.1056/NEJMp2110468

Revisiting FDA approval of aducanumab

G. Caleb Alexander, David S. Knopman, Scott S. Emerson, Bruce Ovbiagele, Richard J. Kryscio, Joel S. Perlmutter, Aaron S. Kesselheim

Research output: Contribution to journal › Review article › peer-review

117 Scopus citations

Original language	English
Pages (from-to)	769-771
Number of pages	3
Journal	New England Journal of Medicine
Volume	385
Issue number	9
DOIs	https://doi.org/10.1056/NEJMp2110468
State	Published - Aug 26 2021

Access to Document

10.1056/NEJMp2110468

Cite this

@article{d0e69fc4f4584407ae5e6ad0e5da23ac,

title = "Revisiting FDA approval of aducanumab",

author = "Alexander, {G. Caleb} and Knopman, {David S.} and Emerson, {Scott S.} and Bruce Ovbiagele and Kryscio, {Richard J.} and Perlmutter, {Joel S.} and Kesselheim, {Aaron S.}",

year = "2021",

month = aug,

day = "26",

doi = "10.1056/NEJMp2110468",

language = "English",

volume = "385",

pages = "769--771",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "9",

}

TY - JOUR

T1 - Revisiting FDA approval of aducanumab

AU - Alexander, G. Caleb

AU - Knopman, David S.

AU - Emerson, Scott S.

AU - Ovbiagele, Bruce

AU - Kryscio, Richard J.

AU - Perlmutter, Joel S.

AU - Kesselheim, Aaron S.

PY - 2021/8/26

Y1 - 2021/8/26

UR - http://www.scopus.com/inward/record.url?scp=85112397387&partnerID=8YFLogxK

U2 - 10.1056/NEJMp2110468

DO - 10.1056/NEJMp2110468

M3 - Review article

C2 - 34320282

AN - SCOPUS:85112397387

SN - 0028-4793

VL - 385

SP - 769

EP - 771

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 9

ER -

Revisiting FDA approval of aducanumab

Access to Document

Other files and links

Cite this